Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 53 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2009-06-08 WACHTER ERIC PHD Vice President Pharmaceuticals Exercise or conversion · Employee Stock Option (Right to Buy) −109,375 $0.64 $70K 105,469
2009-04-01 WACHTER ERIC PHD Vice President Pharmaceuticals Exercise or conversion +46,875 $0.64 $30K 2,532,640
2009-04-01 WACHTER ERIC PHD Vice President Pharmaceuticals Exercise or conversion · Employee Stock Option (Right to Buy) −46,875 214,844
2008-11-20 WACHTER ERIC PHD Vice President Pharmaceuticals Exercise or conversion +66,666 $0.94 $63K 2,485,765
2008-11-20 WACHTER ERIC PHD Vice President Pharmaceuticals Exercise or conversion · Stock Options (right to buy) −66,666 133,334
2008-06-27 WACHTER ERIC PHD Executive VP Pharmaceuticals Grant or award · Stock Options (right to buy) +50,000 50,000
2008-06-27 FUCHS STUART Director Grant or award · Stock Options (right to buy) +50,000 50,000
2008-06-27 SCOTT TIMOTHY PHD President Grant or award · Stock Options (right to buy) +50,000 50,000
2008-06-27 DEES H CRAIG Chief Executive Officer Grant or award · Stock Options (right to buy) +50,000 $1.05 $53K 50,000
2008-06-24 WACHTER ERIC PHD Executive VP Pharmaceuticals Exercise or conversion +30,000 $1.02 $31K 2,419,099
2008-06-24 WACHTER ERIC PHD Executive VP Pharmaceuticals Exercise or conversion · Stock Options (right to buy) −30,000 1,020,000
2008-06-12 CULPEPPER PETER R Chief Financial Officer Exercise or conversion +44,795 $1.10 $49K 260,376
2008-06-12 CULPEPPER PETER R Chief Financial Officer Exercise or conversion · Stock Options (Right to Buy) −44,795 189,624
2008-06-12 CULPEPPER PETER R Chief Financial Officer Exercise or conversion +44,795 $1.10 $49K 110,376
2008-06-12 CULPEPPER PETER R Chief Financial Officer Exercise or conversion · Stock Options (Right to Buy) −44,795 189,624
2008-06-03 McMasters Kelly M Director Exercise or conversion · Stock Options (Right to Buy) +50,000 50,000
2008-06-03 McMasters Kelly M Director Exercise or conversion · Warrant to Purchase Common Shares +10,000 10,000
2008-05-30 WACHTER ERIC PHD Executive VP Pharmaceuticals Exercise or conversion +38,281 $0.64 $24K 2,364,099
2008-05-30 WACHTER ERIC PHD Executive VP Pharmaceuticals Exercise or conversion +25,000 $0.62 $16K 2,389,099
2008-05-30 WACHTER ERIC PHD Executive VP Pharmaceuticals Exercise or conversion · Stock Options (Right to Buy) −38,281 261,719

Page 22 of 28 · 553 trades